Prescription Transfer Among Pharmacies Without Notice

What it is

The agreement authorizes Hims & Hers to transfer user prescriptions among any of the named affiliated pharmacies without providing prior notice to the user. Users provide advance consent to this transfer authority through acceptance of the agreement.

Why it matters (compliance & governance perspective)

This provision establishes a broad transfer authorization that permits prescriptions to be moved among affiliated pharmacies without individual notice or consent at the time of transfer. Pharmacy law in various states imposes specific requirements regarding patient consent and notice for prescription transfers, and the scope of this advance consent may require evaluation against state pharmacy practice regulations.

Consumer impact (what this means for users)

Under this clause, users who accept the agreement consent in advance to their prescriptions being transferred among the named affiliated pharmacies at the platform's discretion without receiving individual notice of each transfer. The named pharmacies include Apostrophe Pharmacy LLC, XeCare LLC, EHT Pharmacy LLC, CD Pharmacy LLC, AnazaoHealth Corporation, and Strive Specialties, Inc. and its affiliates.

Institutional analysis (regulatory & governance intelligence)

REGULATORY LANDSCAPE: State pharmacy practice acts and board of pharmacy regulations in each state where Hims & Hers operates impose specific requirements for prescription transfers, including patient consent, notification, and record-keeping obligations. The DEA's regulations governing controlled substance prescriptions impose additional requirements for any transfers involving controlled substances. State-level patient rights statutes may also be engaged by the advance blanket consent structure. GOVERNANCE EXPOSURE: Medium. The advance blanket consent to prescription transfer without individual notice creates potential exposure under state pharmacy regulations that require contemporaneous patient notification. The scope of the consent depends on how each state's pharmacy board interprets advance contractual consent relative to individual transfer notification requirements. JURISDICTION FLAGS: All states in which Hims & Hers operates present exposure to the extent state pharmacy regulations require individual patient notice for prescription transfers. States with stronger patient rights in pharmacy practice may limit the enforceability of blanket advance consent. Any transfers involving controlled substances face additional DEA regulatory requirements regardless of state pharmacy law. CONTRACT AND VENDOR IMPLICATIONS: The designation of Pharmacies as third-party beneficiaries of this agreement creates contractual dependencies that should be reviewed against each pharmacy's own operating agreements, state licensure requirements, and patient data handling obligations. Procurement teams should assess whether transfers among pharmacies require separate data sharing agreements or business associate agreements for health information. COMPLIANCE CONSIDERATIONS: Legal teams should conduct a state-by-state pharmacy law analysis to determine whether advance contractual consent satisfies individual notification requirements for prescription transfers in each state of operation. Any controlled substance prescriptions should be reviewed separately against DEA requirements. Pharmacy partner agreements should be evaluated to confirm that transfer protocols are consistent with state board of pharmacy requirements.

Applicable agencies

Provision details

Other risks in this policy

• Disclosure Required When Interacting With AI Chatbot medium
• Agreement Revisions Effective Upon Posting high
• Arbitration Opt-Out Within Thirty Days high
• Binding Arbitration Agreement All Disputes high
• Class Action Waiver Jury Trial Waiver high
• Disclaimer Of All Warranties Including Implied Warranties high